Pharmaceutical - Santen Pharmaceuticals

Filter

Current filters:

Santen Pharmaceuticals

Popular Filters

Santen and TRACON link up for TRC105 in ophthalmology

04-03-2014

USA-based TRACON Pharmaceuticals and Japan’s Santen Pharmaceutical have entered into an exclusive agreement…

LicensingPharmaceuticalSanten PharmaceuticalsTRACON PharmaceuticalsTRC105

Akorn gains rights to Betimol from Santen

10-01-2014

US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Bayer files for Japanese approval of Eylea for macular edema following CRVO

07-01-2013

German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry…

afliberceptAsia-PacificBayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationSanten Pharmaceuticals

Santen in ophthalmics deal with Eisai; Sets up new company in China

26-09-2012

Japan's Santen Pharmaceutical (TYO: 4536) has entered into an option agreement with drug major Eisai…

Asia-PacificEisaiLicensingMarkets & MarketingOphthalmicsPharmaceuticalSanten Pharmaceuticals

Santen to co-promote Bayer and Regeneron's Eylea in Japan

09-05-2012

German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

FDA approves Merck & Co’s Zioptan

14-02-2012

The US Food and Drug Administration) has approved drug giant Merck & Co’s (NYSE: MRK) Zioptan (tafluprost…

Merck & CoNorth AmericaOphthalmicsPharmaceuticalRegulationSaflutanSanten PharmaceuticalsZioptan

Mixed half-year results from Astellas, Eisai and Santen

02-11-2011

Compared with some of its peers which reported first-half fiscal year 2011/12 (ended September 30) financial…

Astellas PharmaEisaiFinancialPharmaceuticalSanten Pharmaceuticals

Santen Pharma progresses acquisition of Novagali, gaining 50.55% stake

13-10-2011

Japanese drugmaker Santen Pharmaceuticals (TYO: 4536) says it has completed its previously-announced…

Mergers & AcquisitionsNovagaliOphthalmicsPharmaceuticalSanten Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top